Erratum : Insulin resistance in young, lean male subjects with essential hypertension (Journal of Human Hypertension (201) 25: (391-400) DOI: 10.1038/jhh.2010.72);Insulin resistance in young, lean male subjects with essential hypertension

Journal of Human Hypertension

Volumn 25, Issue 6, 2011, Pages 391-400

  Penesova, A ^a   Cizmarova, E ^b   Belan, V ^c   Blazicek, P ^d   Imrich, R ^a   Vlcek, M ^a   Vigas, M ^a   Selko, D ^e   Koska, J ^a   Radikova, Z ^a  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^b Out patient Clinic Karlova Ves   (Slovakia)

^c Department of Radiology   (Slovakia)

^d Alpha Medical   (Slovakia)

^e NATIONAL INSTITUTE OF CARDIOVASCULAR DISEASES   (Slovakia)

Author keywords

body fat distribution; insulin sensitivity; PAI 1

Indexed keywords

ADIPOCYTOKINE; INSULIN; LIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FATTY ACID BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 79956092732     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.114     Document Type: Erratum

References (62)

1. Moran A, Jacobs Jr DR, Steinberger J, Steffen LM, Pankow JS, Hong CP et al. Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females. Circulation 2008; 117(18): 2361-2368. (Pubitemid 351653543)
2. Gilardini L, Parati G, Sartorio A, Mazzilli G, Pontiggia B, Invitti C. Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity. J Hum Hypertens 2008; 22(2): 75-82.
3. Srinivasan SR, Myers L, Berenson GS. Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects: the Bogalusa Heart Study. Hypertension 2006; 48(1): 33-39. (Pubitemid 44297521)
4. Sinaiko AR, Steinberger J, Moran A, Prineas RJ, Vessby B, Basu S et al. Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation 2005; 111(15): 1985-1991. (Pubitemid 40570219)
5. Sinaiko AR, Steinberger J, Moran A, Hong CP, Prineas RJ, Jacobs Jr DR. Influence of insulin resistance and body mass index at age 13 on systolic blood pressure, triglycerides, and high-density lipoprotein cholesterol at age 19. Hypertension 2006; 48(4): 730-736. (Pubitemid 44843879)
6. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989; 298(6673): 564-567. (Pubitemid 19072097)
7. Rosenberg B, Moran A, Sinaiko AR. Insulin resistance (metabolic) syndrome in children. Panminerva Med 2005; 47(4): 229-244. (Pubitemid 43471967)
8. Despres JP. Health consequences of visceral obesity. Ann Med 2001; 33(8): 534-541. (Pubitemid 33052274)
9. Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE et al. Visceral adiposity and the prevalence of hypertension in Japanese Americans. Circulation 2003; 108(14): 1718-1723. (Pubitemid 37243660)
10. Sironi AM, Gastaldelli A, Mari A, Ciociaro D, Positano V, Buzzigoli E et al. Visceral fat in hypertension: influence on insulin resistance and beta-cell function. Hypertension 2004; 44(2): 127-133. (Pubitemid 39014227)
11. Redon J, Cifkova R, Laurent S, Nilsson P, Narkiewicz K, Erdine S et al. Mechanisms of hypertension in the cardiometabolic syndrome. J Hypertens 2009; 27(3): 441-451.
12. Sarafidis PA, Bakris GL. Insulin resistance, hyperinsulinemia, and hypertension: an epidemiologic approach. J Cardiometab Syndr 2006; 1(5): 334-342; quiz 343.
13. European Society of Hypertension-European Society of Cardiology Guidelines Committee. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21(6): 1011-1053.
14. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114 (2 Suppl., 4th Report): 555-576.
15. Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr 1991; 65(2): 105-114.
16. Mari A, Tura A, Pacini G, Kautzky-Willer A, Ferrannini E. Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes. Diabet Med 2008; 25(6): 671-677. (Pubitemid 351782827)
17. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27(6): 1487-1495. (Pubitemid 38680001)
18. McAuley KA,Williams SM, Mann JI,Walker RJ, Lewis- Barned NJ, Temple LA et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001; 24(3): 460-464. (Pubitemid 32198413)
19. Cederholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 1990; 10(2): 167-175. (Pubitemid 20350538)
20. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22(9): 1462-1470. (Pubitemid 29418240)
21. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M et al. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75(3): 809-817. (Pubitemid 15111002)
22. Reaven GM. Relationship between insulin resistance and hypertension. Diabetes Care 1991; 14(Suppl 4): 33-38.
23. Kautzky-Willer A, Pacini G, Weissel M, Capek M, Ludvik B, Prager R. Elevated hepatic insulin extraction in essential hypertension. Hypertension 1993; 21(5): 646-653. (Pubitemid 23120219)
24. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991; 87(6): 2246-2252.
25. Fossum E, Hoieggen A, Reims HM, Moan A, Rostrup M, Eide I et al. High screening blood pressure is related to sympathetic nervous system activity and insulin resistance in healthy young men. Blood Press 2004; 13(2): 89-94. (Pubitemid 38612809)
26. Saito F, Hori MT, Fittingoff M, Hino T, Tuck ML. Insulin attenuates agonist-mediated calcium mobilization in cultured rat vascular smooth muscle cells. J Clin Invest 1993; 92(3): 1161-1167. (Pubitemid 23273887)
27. Trovati M, Massucco P, Anfossi G, Cavalot F, Mularoni E, Mattiello L et al. Insulin influences the renin-angiotensin-aldosterone system in humans. Metabolism 1989; 38(6): 501-503. (Pubitemid 19145761)
28. DeFronzo RA. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia 1981; 21(3): 165-171. (Pubitemid 11049307)
29. Navegantes LC, Sjostrand M, Gudbjornsdottir S, Strindberg L, Elam M, Lonnroth P. Regulation and counterregulation of lipolysis in vivo: different roles of sympathetic activation and insulin. J Clin Endocrinol Metab 2003; 88(11): 5515-5520. (Pubitemid 37452764)
30. Radikova Z, Penesova A, Cizmarova E, Huckova M, Kvetnansky R, Vigas M et al. Decreased pituitary response to insulin-induced hypoglycaemia in young lean male patients with essential hypertension. J Hum Hypertens 2006; 20(7): 510-516. (Pubitemid 43923121)
31. Boden G. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp Clin Endocrinol Diabetes 2003; 111(3): 121-124. (Pubitemid 36682048)
32. Magnan C, Cruciani C, Clement L, Adnot P, Vincent M, Kergoat M et al. Glucose-induced insulin hypersecretion in lipid-infused healthy subjects is associated with a decrease in plasma norepinephrine concentration and urinary excretion. J Clin Endocrinol Metab 2001; 86(10): 4901-4907. (Pubitemid 33020539)
33. Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 2003; 52(10): 2461-2474. (Pubitemid 37210533)
34. Hennes MM, Dua A, Kissebah AH. Effects of free fatty acids and glucose on splanchnic insulin dynamics. Diabetes 1997; 46(1): 57-62. (Pubitemid 27009950)
35. Piche ME, Lemieux S, Perusse L, Weisnagel SJ. High normal 2-h plasma glucose is associated with insulin sensitivity and secretion that may predispose to type 2 diabetes. Diabetologia 2005; 48(4): 732-740. (Pubitemid 40591229)
36. Boyko EJ, Barr EL, Zimmet PZ, Shaw JE. Two-hour glucose predicts the development of hypertension over 5 years: the AusDiab study. J Hum Hypertens 2008; 22(3): 168-176. (Pubitemid 351266484)
37. Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 2002; 51(4): 1005-1015. (Pubitemid 34438343)
38. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998; 47(5): 699-713. (Pubitemid 28201798)
39. Toft I, Bonaa KH, Jenssen T. Insulin resistance in hypertension is associated with body fat rather than blood pressure. Hypertension 1998; 32(1): 115-122. (Pubitemid 28324134)
40. Brooks NL, Moore KS, Clark RD, Perfetti MT, Trent CM, Combs TP. Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome? Diabetes Obes Metab 2007; 9(3): 246-258. (Pubitemid 46502042)
41. Beltowski J. Role of leptin in blood pressure regulation and arterial hypertension. J Hypertens 2006; 24(5): 789-801. (Pubitemid 43670444)
42. Sung SH, Chuang SY, Sheu WH, Lee WJ, Chou P, Chen CH. Adiponectin, but not leptin or high-sensitivity C-reactive protein, is associated with blood pressure independently of general and abdominal adiposity. Hypertens Res 2008; 31(4): 633-640. (Pubitemid 351772853)
43. Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism 2006; 55(11): 1551-1557. (Pubitemid 44537354)
44. Stegenga ME, van der Crabben SN, Blumer RM, Levi M, Meijers JC, Serlie MJ et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood 2008; 112(1): 82-89.
45. Palomo I, Alarcon M, Moore-Carrasco R, Argiles JM. Hemostasis alterations in metabolic syndrome (review). Int J Mol Med 2006; 18(5): 969-974.
46. Barac A, Campia U, Panza JA. Methods for evaluating endothelial function in humans. Hypertension 2007; 49(4): 748-760. (Pubitemid 351664221)
47. Juhan-Vague I, Morange PE, Frere C, Aillaud MF, Alessi MC, Hawe E et al. The plasminogen activator inhibitor-1-675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study. J Thromb Haemost 2003; 1(11): 2322-2329.
48. Laugero KD, Stonehouse AH, Guss S, Landry J, Vu C, Parkes DG. Exenatide improves hypertension in a rat model of the metabolic syndrome. Metab Syndr Relat Disord 2009; 7(4): 327-334.
49. Hirata K, Kume S, Araki S, Sakaguchi M, Chin-Kanasaki M, Isshiki K et al. Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model. Biochem Biophys Res Commun 2009; 380(1): 44-49.
50. Yu M, Moreno C, Hoagland KM, Dahly A, Ditter K, Mistry M et al. Antihypertensive effect of glucagonlike peptide 1 in Dahl salt-sensitive rats. J Hypertens 2003; 21(6): 1125-1135. (Pubitemid 36667866)
51. Okerson T, Yan P, Stonehouse A, Brodows R. Effects of exenatide on systolic blood pressure in subjects with type 2 diabetes. Am J Hypertens 2010; 23(3): 334-339.
52. Sjöholm A. Impact of glucagon-like peptide-1 on endothelial function. Diabetes Obes Metab 2009; 11(Suppl 3): 19-25.
53. Cabou C, Campistron G, Marsollier N, Leloup C, Cruciani-Guglielmacci C, Pénicaud L et al. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity. Diabetes 2008; 57(10): 2577-2587.
54. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990; 39(2): 167-174. (Pubitemid 20053276)
55. Ferrari P, Weidmann P, Shaw S, Giachino D, Riesen W, Allemann Y et al. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med 1991; 91(6): 589-596.
56. Beatty OL, Harper R, Sheridan B, Atkinson AB, Bell PM. Insulin resistance in offspring of hypertensive parents. BMJ 1993; 307(6896): 92-96. (Pubitemid 23189568)
57. Ohno Y, Suzuki H, Yamakawa H, Nakamura M, Otsuka K, Saruta T. Impaired insulin sensitivity in young, lean normotensive offspring of essential hypertensives: possible role of disturbed calcium metabolism. J Hypertens 1993; 11(4): 421-426. (Pubitemid 23139785)
58. Endre T, Mattiasson I, Hulthen UL, Lindgarde F, Berglund G. Insulin resistance is coupled to low physical fitness in normotensive men with a family history of hypertension. J Hypertens 1994; 12(1): 81-88. (Pubitemid 24044012)
59. Vlasakova Z, Pelikanova T, Karasova L, Skibova J. Insulin secretion, sensitivity, and metabolic profile of young healthy offspring of hypertensive parents. Metabolism 2004; 53(4): 469-475. (Pubitemid 38419190)
60. Papadopoulos DP, Makris TK, Perrea D, Papazachou O, Daskalaki M, Sanidas E et al. Adiponectin-insulin and resistin plasma levels in young healthy offspring of patients with essential hypertension. Blood Press 2008; 17(1): 50-54. (Pubitemid 351890492)
61. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237(3): E214-E223. (Pubitemid 9249478)
62. Radikova Z, Koska J, Huckova M, Ksinantova L, Imrich R, Vigas M et al. Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulinresistant subjects. Exp Clin Endocrinol Diabetes 2006; 114(5): 249-256. (Pubitemid 44065178)